Definitive Contract HHSN268200700022C

This is a $99,911 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services (HHS). The contract was awarded to Luna Innovations Incorporated, a small business manufacturer specializing in advanced fiber optic sensing and measurement systems. The contract supports the development of "Critical Technologies for Ventricular Assist Devices," a research...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to LIG Sciences, Inc. for the development of "Critical Technologies for Ventricular Assist Devices." The firm fixed-price contract, valued at $99,616.00, was awarded on September 30, 2007 with a completion date of March 31, 2008. As an SBIR Phase I contract, this award is intended to support the early-stage research and development of...

This federal contract award with ID HHSN268200700021C was made by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, to Biosurfaces Inc., a for-profit small business. The $100,000 firm fixed-price contract is for the development of critical technologies for ventricular assist devices under the SBIR Phase I program. The contract has a period of performance from September 30, 2007 to June 17, 2009. Biosurfaces Inc. specializes in...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Aphios Corp, a minority-owned for-profit small business. The contract has a ceiling value of $149,440 and a completion date of December 14, 2011. It was awarded on June 15, 2011 under the SBIR program to support research related to Topic 43. SBIR contracts provide early-stage funding to small businesses for the development of innovative...

<p>This is a $201,498.00 Firm Fixed Price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to Inceptus Medical, LLC, a small business. The contract is for R&amp;D under the SBIR Program Phase I and has a completion date of July 19, 2016. This is a definitive contract with no set-aside designation. The contract does not appear to be associated with a larger contract vehicle.</p>

<p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, valued at $249,723.00, was awarded to Detroit R&amp;D, Inc., a minority-owned, economically disadvantaged, woman-owned small business located in Bloomfield Hills, Michigan. The contract is for research and development of a &quot;Multiplex Label-Free Nanowell Technology...

This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...

<p>This is a $100,037.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Synzyme Technologies LLC, a for-profit limited liability company. The contract is for the production of stroma-free hemoglobin and hemoglobin-based oxygen carriers (HBOCs). It is a firm-fixed-price definitive contract with a period of performance ending on May 29, 2009.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...